1985
DOI: 10.1182/blood.v66.2.439.439
|View full text |Cite
|
Sign up to set email alerts
|

In vitro culture of leukemic cells in t(4;11) acute leukemia

Abstract: In the present study we utilized a semisolid culture system with feeder cells and enriched media to evaluate the growth of acute leukemia associated with the 4;11 chromosomal translocation. We compared growth of t(4;11) leukemia to typical acute nonlymphocytic leukemia (ANL) and acute lymphocytic leukemia (ALL). The two cases of t(4;11) leukemia tested exhibited the highest cloning efficiency of cells tested. The growth characteristics of t(4;11) leukemia were more similar to ANL than ALL.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0
1

Year Published

1986
1986
1997
1997

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(7 citation statements)
references
References 19 publications
0
6
0
1
Order By: Relevance
“…Among approximately 300 published cases in 15 studies, no leukemic colonies were observed in one third of patients and, even if colonies were generated in the remaining two thirds, plating efficiency was much lower than in the case of AML, ranging from 0.001% to 2.76%, with an overall median value of only 0.28% [72]. It has been reported that Philadelphia chromosomeor myeloid-antigen-positive ALL cases tend to show colony formation in response to myeloid growth factors, suggesting that ALL blasts with bipotential phenotypes grow more like AML blasts [66,69,70]. The poor colony forming capability of ALL blast progenitors compared to those from AML cases could be due, in part, to culture conditions under which ALL blasts easily undergo apoptosis even in the presence of added HGFs.…”
Section: Leukemic Stem Cells In Allmentioning
confidence: 96%
See 1 more Smart Citation
“…Among approximately 300 published cases in 15 studies, no leukemic colonies were observed in one third of patients and, even if colonies were generated in the remaining two thirds, plating efficiency was much lower than in the case of AML, ranging from 0.001% to 2.76%, with an overall median value of only 0.28% [72]. It has been reported that Philadelphia chromosomeor myeloid-antigen-positive ALL cases tend to show colony formation in response to myeloid growth factors, suggesting that ALL blasts with bipotential phenotypes grow more like AML blasts [66,69,70]. The poor colony forming capability of ALL blast progenitors compared to those from AML cases could be due, in part, to culture conditions under which ALL blasts easily undergo apoptosis even in the presence of added HGFs.…”
Section: Leukemic Stem Cells In Allmentioning
confidence: 96%
“…Attempts to demonstrate the leukemic stem cells in acute lymphoblastic leukemia (ALL), particularly common ALL or pre-B-ALL, have been made, but leukemic colony assays for ALL have been difficult to establish and relatively little data reported [63][64][65][66][67][68][69][70][71]. For ALL colony assays, feeder cells from irradiated peripheral blood are required together with soluble growth stimulants, including PHA-LCM.…”
Section: Leukemic Stem Cells In Allmentioning
confidence: 99%
“…Human cell lines studied were: RC-K8, from a B-cell lymphoma with t( 11; 14)(q23;q32) (Kubonishi et al, 1986); KOCL-33, from an infantile acute leukemia with t(11;19)(q23;p13) (Akao et al, 1991b); and RS4;11, from an acute leukemia with t(4;11)(q21;q23) (Stong and Kersey, 1985). An Epstein-Barr virus-transformed cell with a normal karyotype was used as a control.…”
Section: Cellsmentioning
confidence: 99%
“…We (14-17, 24, 25) and others (7,9,10,26) have discussed the problems inherent in using established ceil lines in vitro as a model system for evaluating the antileukemic efficacy of a purging reagent. These problems have received little attention because of the difficulty in growing freshly obtained ALL cells in vitro (26,27). To our knowledge, none of the reagents currently under clinical evaluation have been tested directly against clonogenic blasts from ALL patients, and therefore there is no evidence that they can effectively eliminate leukemic progenitor cells.…”
mentioning
confidence: 99%